A rapid, high-throughput, viral infectivity assay using automated brightfield microscopy with machine learning
Description
Infectivity assays are essential for the development of viral vaccines, antiviral therapies, and the manufacture of biologicals. Traditionally, these assays take 2-7 days and require several manual processing steps after infection. We describe an
